Evaluation of Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide in Patients With Relapsed and Refractory Myeloma.
Phase of Trial: Phase I/II
Latest Information Update: 26 May 2017
At a glance
- Drugs Pomalidomide (Primary) ; Cyclophosphamide; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 02 Sep 2016 Status changed from active, no longer recruiting to completed.
- 26 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Nov 2016.
- 26 Apr 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Nov 2016.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History